Canada Pension Plan Investment Board’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,700
| Closed | -$19.8K | – | 1488 |
|
|
2024
Q2 | $19.8K | Hold |
7,700
| – | – | ﹤0.01% | 1324 |
|
|
2024
Q1 | $37.9K | Hold |
7,700
| – | – | ﹤0.01% | 1152 |
|
|
2023
Q4 | $67.7K | Hold |
7,700
| – | – | ﹤0.01% | 1051 |
|
|
2023
Q3 | $88.3K | Buy |
+7,700
| New | +$88.3K | ﹤0.01% | 961 |
|
|
2023
Q2 | – | Sell |
-167,568
| Closed | -$5.4M | – | 1122 |
|
|
2023
Q1 | $5.4M | Buy |
+167,568
| New | +$5.4M | 0.01% | 565 |
|
|
2018
Q3 | – | Sell |
-582,900
| Closed | -$16M | – | 1328 |
|
|
2018
Q2 | $16M | Hold |
582,900
| – | – | 0.03% | 440 |
|
|
2018
Q1 | $18M | Hold |
582,900
| – | – | 0.03% | 446 |
|
|
2017
Q4 | $20.8M | Hold |
582,900
| – | – | 0.04% | 358 |
|
|
2017
Q3 | $16.1M | Hold |
582,900
| – | – | 0.03% | 403 |
|
|
2017
Q2 | $15.4M | Hold |
582,900
| – | – | 0.04% | 372 |
|
|
2017
Q1 | $12.1M | Hold |
582,900
| – | – | 0.03% | 409 |
|
|
2016
Q4 | $12.1M | Hold |
582,900
| – | – | 0.04% | 314 |
|
|
2016
Q3 | $9.45M | Sell |
582,900
-27,400
| -4% | -$444K | 0.03% | 369 |
|
|
2016
Q2 | $8.3M | Hold |
610,300
| – | – | 0.03% | 394 |
|
|
2016
Q1 | $10.7M | Hold |
610,300
| – | – | 0.04% | 351 |
|
|
2015
Q4 | $20.8M | Hold |
610,300
| – | – | 0.1% | 162 |
|
|
2015
Q3 | $18.2M | Buy |
+610,300
| New | +$18.2M | 0.07% | 235 |
|